Loading…
Loading…
Benefit-sharing from DSI rests on the provider country's national framework. Where it requires bilateral benefit-sharing for DSI, those terms apply. Where it gives effect to the CBD multilateral mechanism, users of its publicly available DSI should share benefits through it: all users non-monetary benefits, as appropriate, and commercial users above set size thresholds also monetary contributions to the Cali Fund. Where it is silent on DSI, the position is not yet settled: check with the country's competent national authority, through the ABS service. Any terms agreed when the genetic resources were accessed still apply. Access and benefit-sharing questions are handled by the ABS service, not by the DataBank. Learn more →
458 aa — origin: hub — derived from genome record #782
publiccc_byAFDSI-PROT-78860 downloads
Not yet annotated.
NALF1 — v4
pLDDT confidence: unknown
Bound ligands/cofactors: 2-acetamido-2-deoxy-beta-D-glucopyranose, (1S)-2-{[(2-AMINOETHOXY)(HYDROXY)PHOSPHORYL]OXY}-1-[(PALMITOYLOXY)METHYL]ETHYL STEARATE, (1R)-2-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PALMITOYLOXY)METHYL]ETHYL (11E)-OCTADEC-11-ENOATE, CHOLESTEROL HEMISUCCINATE
1 download
v3 — pLDDT unknown
v2 — pLDDT 61.2
v1 — pLDDT 61.2